Innovations in Care Delivery
Editors' Blog
-
Editors' Top Five Recommended Reading
- Geographic variation in neurologist density and neurologic care in the United States
Chun Chieh Lin, Brian C. Callaghan, James F. Burke, Lesli E. Skolarus, Chloe E. Hill, Brandon Magliocco, Gregory J. Esper, Kevin A. Kerber
- Increasing Out-of-Pocket Costs for Neurologic Care for Privately-Insured Patients
Chloe E. Hill, Evan L. Reynolds, James F. Burke, Mousumi Banerjee, Kevin A. Kerber, Brandon Magliocco, Gregory J. Esper, Lesli E. Skolarus, Brian C. Callaghan
- Quality and safety analysis of 2999 telemedicine encounters during the COVID-19 pandemic.
Charuta N Joshi, Michele L Yang, Krista Eschbach, Suhong Tong, Mona P Jacobson, Chelsey Stillman, Annmarie E Kropp, Stephanie A Shea, Gerard M Frunzi, J Fred Thomas, Christina A Olson
- A Bronx Tale: Disparities in Access to Neurologic Telemedicine During the COVID-19 Pandemic
Jonathan M. Gursky, Alex Boro, Sheri Escalante, Victor Ferastraoaru, Rajani Hanumanthu, Sheryl Haut, Rana Jehle, Isaac Molinero, Lindsay Rick, Jillian Rosengard, Mohammad Saifeddine, William Sugrue, Solomon L. Moshé, Karen Ballaban-Gil
- Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus
Elan L. Guterman, Joseph K. Sanford, John P. Betjemann, Li Zhang, James F. Burke, Daniel H. Lowenstein, S. Andrew Josephson, Karl A. Sporer
- Geographic variation in neurologist density and neurologic care in the United States
Latest Articles
-
Browse Subcategories
-
Interview With A Health Services Expert
Dr. Kevin Kerber interviews Dr. Ralph Sacco
Dr. Sacco talks about his leadership role in balancing the needs of neurologists, the department and other stake holders with the needs of patients. He outlines successful approaches to improving patient access to quality care, the challenges in implementing these approaches, and what he sees as the future in care delivery .
In April of 2017, Drs. Kerber and Callaghan had the chance to talk to Ralph L. Sacco, MD, MS, University of Miami Miller School of Medicine where Dr. Sacco is Chairman & Professor Department of Neurology, Director and Principal Investigator of the University of Miami Clinical and Translational Science Institute, Executive Director Evelyn F McKnight Brain Institute, Miller Professor of Epidemiology, Public Health Sciences, Human Genetics, and Neurosurgery, Olemberg Family Chair in Neurological Disorders and Senior Associate Dean for Clinical & Translational Science. Dr. Sacco is also the President of the American Academy of Neurology.
N A M E: Ralph L. Sacco, MD, MS, FAHA, FAAN
T I T L E: Chairman & Professor Department of Neurology; Director and Principal Investigator of the University of Miami Clinical and Translational Science Institute; Executive Director Evelyn F McKnight Brain Institute; Miller Professor of Epidemiology, Public Health Sciences, Human Genetics, and Neurosurgery; Olemberg Family Chair in Neurological Disorders; and Senior Associate Dean for Clinical & Translational Science.
E D U C A T I O N: Dr. Sacco is a graduate of Cornell University and graduated cum laude from Boston University School of Medicine. He holds a master’s in epidemiology from Columbia University, School of Public Health and completed his residency training and postdoctoral training in stroke and epidemiology at New York’s Columbia Presbyterian.
H O B B I E S: Renovating homes in NY, biking, and volunteer work.
Podcasts
-
Call to Action!
Neurology: Clinical Practice has launched their next Practice Current survey on a universally controversial topic —Practice Current: How do you manage mild cognitive impairment? Please consider completing the survey to add your own perspective.
An important perspective about new medical equipment in low resource countries - Dr. Omar Siddiqi, Assistant Professor of Neurology at Harvard Medical School and the Director of the Global Neurology Program at Beth Israel Deaconess Medical Center, shares his experiences with the unforeseen negatives to innovative, medical technology in resource limited settings. He states, 'Near as I can tell, the only purpose they serve is to charge patients for a sham test.’ ”
-
RESOURCES
Disease Modifying Therapy in Alzheimer’s Disease; Tenecteplase vs Alteplase in Basilar OcclusionMarch 2, 2021 IssueNeurology, Journal, Podcast